Comparison of Real-World Costs, Healthcare Resource Utilization, and Comorbidity-Related Costs Between Ixekizumab and Secukinumab Among Biologic-Experienced Patients with Psoriasis Over 18 Months in the USA. - Blauvelt, Andrew; Shi, Nianwen; Somani, Najwa; Burge, Russel; Zhu, Baojin; Ridenour, Terri; Kern, Scott; Lew, Carolyn; Zimmerman, Nicole; Murage, Mwangi (Clinical Drug Investigation, 2023)